Compare · CCXI vs OXSQ

CCXI vs OXSQ

Side-by-side comparison of Churchill Capital Corp XI (CCXI) and Oxford Square Capital Corp. (OXSQ): market cap, price performance, sector, and recent activity on the wire.

Summary

  • Both CCXI and OXSQ operate in Blank Checks (Finance), so they compete in similar markets.
  • OXSQ carries a market cap of $91.8M.
  • Over the past year, CCXI is up 8.8% and OXSQ is down 59.0% - CCXI leads by 67.8 points.
  • CCXI has been more active in the news (40 items in the past 4 weeks vs 3 for OXSQ).
  • CCXI has more recent analyst coverage (8 ratings vs 0 for OXSQ).
PerformanceCCXI+8.81%OXSQ-57.37%
2026-02-09+0.00%2026-11-04
MetricCCXIOXSQ
Company
Churchill Capital Corp XI
Oxford Square Capital Corp.
Price
-
-
Market cap
-
$91.8M
1M return
-5.59%
-44.99%
1Y return
+8.81%
-58.96%
Industry
Blank Checks
Blank Checks
Exchange
NASDAQ
NASDAQ
IPO
2026
2003
News (4w)
40
3
Recent ratings
8
0
CCXI

Churchill Capital Corp XI

ChemoCentryx, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. It develops Avacopan, an orally administered selective complement 5a receptor inhibitor for the treatment of anti-neutrophil cytoplasmic autoantibody-associated vasculitis; and completed Phase II clinical trial for the treatment of patients with severe hidradenitis suppurativa, as well as patients with complement 3 glomerulopathy. The company is also developing CCX559, an orally-administered inhibitor for programmed death protein 1/programmed death-ligand 1 for the treatment of various cancers; and CCX507, an orally-administered inhibitor of the chemokine receptor CC9, which has completed Phase I clinical trial or the treatment of inflammatory bowel disease. In addition, it develops CCX587 for the treatment of TH17 driven diseases. ChemoCentryx, Inc. was incorporated in 1996 and is headquartered in Mountain View, California.

OXSQ

Oxford Square Capital Corp.

Oxford Square Capital Corp. is a business development company, operates as a closed-end, non-diversified management investment company. It is a private equity and mezzanine firm. The firm invests in both public and private companies. It invests in secured and unsecured senior debt, subordinated debt, junior subordinated debt, preferred stock, common stock and syndicated bank loans. The firm primarily invests in debt and/or equity securities of technology-related companies that operate in the computer software, Internet, information technology infrastructure and services, media, telecommunications and telecommunications equipment, semiconductors, hardware, technology-enabled services, semiconductor capital equipment, medical device technology, diversified technology, and networking systems sectors. It concentrates its investments in companies having annual revenues of less than $200 million and a market capitalization or enterprise value of less than $300 million. The firm invests between $5 million and $30 million per transaction. It seeks to exit its investments within 7 years. It serves as the investment adviser to TICC. Oxford Square Capital Corp., formerly known as TICC Capital Corp., was founded in 2003 and is headquartered in Greenwich, Connecticut.

Latest CCXI

Latest OXSQ